Resource Centre
Case study )
Testimonial: Yaw Bediako
Case study )
Case study: Oxford Nanopore sequencing at large cohort scale — new insights from the NIHR BioResource
Case study )
Case study: is the end to the diagnostic odyssey within reach?
Case study )
Case study: expanding reference genomes with T2T assembly to reflect global diversity
Case study )
Case study: unravelling tumour biology with single-cell Oxford Nanopore sequencing
Case study )
Case study: exploring the future of rapid leukaemia diagnosis with a single-platform workflow
Case study )
Case study: streamlining routine CRISPR validation with Oxford Nanopore sequencing
Case study )
Testimonial: Vorasuk Shotelersuk
Case study )
Testimonial: Ahmad Abou Tayoun
Case study )
Testimonial: Jonathan Mill
Case study )
Testimonial: Thidathip Wongsurawat
Case study )
Case study: accurate identification of cancer-predisposing deep intronic variants in tumour-suppressor genes with Oxford Nanopore sequencing
Case study )
Case study: solving the parent-of-origin effect in retinoblastoma to determine disease severity
Case study )
Case study: improving the characterisation of acute paediatric leukaemia worldwide
Case study )
Case study: revealing hidden biology with isoform-level single-cell transcriptomics
Case study )
Case study: full-length RNA isoforms deliver new insights into human health and disease
Case study )
Case study: delivering ‘unique insights’ into infection with direct RNA sequencing
Case study )
Case study: tackling poliovirus outbreaks and eliminating cell-culture detection methods with nanopore technology
Case study )
Case study: combating viral contamination and disease outbreaks at source with rapid, low-cost nanopore sequencing
Case study )
Case study: culture-free, strain-level characterisation of foodborne pathogens using targeted nanopore metagenomics
